BTK INHIBITORS
Clinical trials for BTK INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new BTK INHIBITORS trials appear
Sign up with your email to follow new studies for BTK INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tame stubborn blood disorders
Disease control Not yet recruitingThis early-phase study tests whether combining two drugs (Zuberitamab and Orelabrutinib) can help people with immune thrombocytopenia (ITP) or autoimmune hemolytic anemia (AIHA) that hasn't responded to other treatments. The drugs work together to calm the immune system and stop …
Matched conditions: BTK INHIBITORS
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Which cancer drug is safer for the heart? large study aims to find out
Knowledge-focused Not yet recruitingThis study looks at medical records of 15,000 adults with chronic B-cell cancers to compare the risk of developing atrial fibrillation (an irregular heartbeat) between two drugs, zanubrutinib and acalabrutinib. Researchers will analyze data from a health database to see which dru…
Matched conditions: BTK INHIBITORS
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC